Putnam Investments’s 2seventy bio TSVT Stock Holding History

Putnam Investments’s Portfolio TSVT Stock Details TSVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-72,917	Closed	-$286K	–	1225
2023 Q3	$286K	Buy	72,917 +32,839	+82%	+$215K	﹤0.01%	1076
2023 Q2	$406K	Buy	40,078 +2,795	+7%	+$29.6K	﹤0.01%	978
2023 Q1	$380K	Buy	37,283 +15,217	+69%	+$174K	﹤0.01%	1003
2022 Q4	$207K	Sell	22,066 -4,673	-17%	-$65.9K	﹤0.01%	1112
2022 Q3	$389K	Buy	+26,739	New	+$397K	﹤0.01%	994
2022 Q1	–	Sell	-19,646	Closed	-$503K	–	1257
2021 Q4	$503K	Buy	+19,646	New	+$613K	﹤0.01%	1020

Other funds holding TSVT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

ECM

Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Putnam Investments's TSVT Position: Q4 2023 in Review

Putnam Investments sold out of 2seventy bio (TSVT) in Q4 2023, closing a stake of 72,917 shares — an estimated $286K sold.

Putnam Investments first reported a position in TSVT in Q4 2021 and held it in 6 quarters. The position peaked at $503K in Q4 2021. 116 funds tracked by Wall St. Rank hold TSVT as of Q4 2023.

Putnam Investments reported no remaining 2seventy bio position as of Q4 2023 after selling out during the quarter.
Putnam Investments sold 72,917 2seventy bio shares in Q4 2023, an estimated $286K.
Putnam Investments first reported a position in 2seventy bio in Q4 2021 and held it in 6 quarters.
Putnam Investments's 2seventy bio position peaked at $503K in Q4 2021.
116 funds tracked by Wall St. Rank held 2seventy bio as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.